Company Filing History:
Years Active: 2025
Title: The Innovations of Hannah Jörissen
Introduction
Hannah Jörissen is a notable inventor based in Heiligenhaus, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. Her work has implications for medical treatments and therapeutic applications.
Latest Patents
Hannah Jörissen holds 1 patent for her invention titled "Atrial natriuretic peptide engrafted antibodies." This invention relates to an antibody or a fragment that includes at least one heterologous amino acid sequence within its CDR regions. The invention features an N-terminal linker sequence, an Atrial Natriuretic Peptide (ANP), and a C-terminal linker sequence. Additionally, portions of the CDR region may be replaced by the heterologous amino acid sequence. This invention also encompasses methods for treatment, compositions, nucleic acids encoding the antibody, host cells, and processes for producing the antibody or its fragments.
Career Highlights
Throughout her career, Hannah has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to develop her expertise in biotechnology and patentable innovations.
Collaborations
Hannah has collaborated with several professionals in her field, including Anke Mayer-Bartschmid and Damian Brockschnieder. These collaborations have contributed to her innovative work and advancements in antibody technology.
Conclusion
Hannah Jörissen is a pioneering inventor whose work in antibody development showcases her commitment to advancing medical science. Her contributions are significant and continue to influence the field of biotechnology.